Search - tctmd.com

Displaying 1 - 20 of 108

Sort: Relevancy | Date

Presentation TCT 2017

PREVAIL: 5-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure vs Medical Therapy in Patients With Nonvalvular Atrial Fibrillation

Presenter: Saibal Kar

November 02, 2017

Presentation TCT 2017

Is Ablation an Alternative to Triple Therapy in Patients With Atrial Fibrillation and PCI or ACS?

Presenter: Samir R. Kapadia, Ioanna Kosmidou

November 01, 2017

Presentation TCT 2017

Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure?

Presenter: Samir R. Kapadia, David J. Moliterno

November 01, 2017

Presentation TCT 2017

Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping

Presenter: Samir R. Kapadia, Sameer Gafoor

November 01, 2017

Presentation TCT 2017

Is LAA Closure an Alternative to Triple Therapy for All Patients or Just Those at High Bleeding Risk? Current Dataset

Presenter: Samir R. Kapadia, Brian K. Whisenant

November 01, 2017

Presentation TCT 2017

Rationale and Potential Role for LAA Closure in the PCI and ACS Patient

Presenter: Samir R. Kapadia, Ashish Pershad

November 01, 2017

Presentation TCT 2017

MitraClip or TAVR With Left Atrial Appendage Closure

Presenter: A. Pieter Kappetein, Georg Nickenig, Ramon Quesada

November 01, 2017

Presentation TCT 2017

Left Atrial Appendage Closure With a Novel Device: Initial Experience and Short-term Follow-up From a Single Center

Presenter: Daniel Burkhoff, Samir R. Kapadia, Giulio G. Stefanini

November 01, 2017

Presentation TCT 2017

My Most Challenging LAA Closure Case: Twice As Many Problems As Usual

Presenter: Matthew J. Price, Jacqueline Saw, Petr Neuzil

October 31, 2017

Presentation TCT 2017

Medical Treatment After LAA Closure: Trade-off of Bleeding vs Device-Related Thrombus

Presenter: Matthew J. Price, Jacqueline Saw, Lucas V. Boersma

October 31, 2017

Presentation TCT 2017

Residual Leaks After LAA Closure: Frequency, Prevention, and Treatment (With Case Reviews)

Presenter: Matthew J. Price, Jacqueline Saw, Kolja Sievert

October 31, 2017

Presentation TCT 2017

Device Embolization: Frequency, Prevention, and Treatment (With Case Reviews)

Presenter: Matthew J. Price, Jacqueline Saw, Brian K. Whisenant

October 31, 2017

Presentation TCT 2017

Periprocedural Effusions and Tamponade: Frequency, Prevention, and Treatment (With Case Reviews)

Presenter: Matthew J. Price, Jacqueline Saw, Martin W. Bergmann

October 31, 2017

Presentation TCT 2017

PROLIPSIS: Device Description, Data, and Future Directions

Presenter: Mark Reisman, Josep Rodés-Cabau, Eleftherios Sideris

October 31, 2017

Presentation TCT 2017

SeaLA: Device Description, Data, and Future Directions

Presenter: Mark Reisman, Josep Rodés-Cabau, Kolja Sievert

October 31, 2017

Presentation TCT 2017

Occlutech LAA Occluder: Device Description, Data, and Future Directions

Presenter: Mark Reisman, Josep Rodés-Cabau, Kolja Sievert

October 31, 2017

Presentation TCT 2017

WaveCrest: Device Description, Data, and Future Directions

Presenter: Mark Reisman, Josep Rodés-Cabau, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

Ultraseal LAA Occluder: Device Description, Data, and Future Directions

Presenter: Mark Reisman, Josep Rodés-Cabau

October 31, 2017

Presentation TCT 2017

Lambre: Device Description, Data, and Future Directions

Presenter: Mark Reisman, Josep Rodés-Cabau, Yat Sun Joseph Chan

October 31, 2017

Presentation TCT 2017

LARIAT: LAA Occlusion, Electrical Isolation, or Both?

Presenter: Mark Reisman, Josep Rodés-Cabau, DJ Lakkireddy

October 31, 2017

Advertisement

PREVAIL: 5-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure vs Medical Therapy in Patients With Nonvalvular Atrial Fibrillation

Is Ablation an Alternative to Triple Therapy in Patients With Atrial Fibrillation and PCI or ACS?

Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure?

Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping

Is LAA Closure an Alternative to Triple Therapy for All Patients or Just Those at High Bleeding Risk? Current Dataset

Rationale and Potential Role for LAA Closure in the PCI and ACS Patient

MitraClip or TAVR With Left Atrial Appendage Closure

Left Atrial Appendage Closure With a Novel Device: Initial Experience and Short-term Follow-up From a Single Center

My Most Challenging LAA Closure Case: Twice As Many Problems As Usual

Medical Treatment After LAA Closure: Trade-off of Bleeding vs Device-Related Thrombus

Residual Leaks After LAA Closure: Frequency, Prevention, and Treatment (With Case Reviews)

Device Embolization: Frequency, Prevention, and Treatment (With Case Reviews)

Periprocedural Effusions and Tamponade: Frequency, Prevention, and Treatment (With Case Reviews)

PROLIPSIS: Device Description, Data, and Future Directions

SeaLA: Device Description, Data, and Future Directions

Occlutech LAA Occluder: Device Description, Data, and Future Directions

WaveCrest: Device Description, Data, and Future Directions

Ultraseal LAA Occluder: Device Description, Data, and Future Directions

Lambre: Device Description, Data, and Future Directions

LARIAT: LAA Occlusion, Electrical Isolation, or Both?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content